Patents by Inventor Klaus Eistetter

Klaus Eistetter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Device for dosing and dry nebulization
    Patent number: 9713682
    Abstract: The invention relates to a device 1 for dosing and dry nebulization of nebulizable material 12 chosen from the group comprising anti-infective agents and immunomodulators, comprising a nebulization channel 3, which has a first attachment piece and a second attachment piece, and a source of compressed carrier gas connected to the first attachment piece via a valve 16 for the purpose of sending a carrier gas pressure pulse into the nebulization channel. The device is characterized in that between the first attachment piece and second attachment piece, and above the nebulization channel, a reservoir 10 open only towards the nebulization channel, which contains the nebulizable material 12, is connected to the nebulization channel such that it is gas-tight with respect to the environment, and that, when the valve is closed, a pressure compensation takes place in the nebulization channel and in the reservoir.
    Type: Grant
    Filed: April 7, 2006
    Date of Patent: July 25, 2017
    Assignee: Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.
    Inventors: Klaus Eistetter, Wilhelm Wurst, Gerhard Pohlmann, Horst Windt, Oliver Nolte, Wolfgang Koch
  • Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient
    Patent number: 9468598
    Abstract: Dosage forms for oral administration of a PDE 4 inhibitor whose solubility is slight are described. They contain PVP as binder.
    Type: Grant
    Filed: April 30, 2013
    Date of Patent: October 18, 2016
    Assignee: AstraZeneca AB
    Inventors: Rango Dietrich, Klaus Eistetter, Hartmut Ney
  • Oral Dosage Form Containing A PDE 4 Inhibitor as an Active Ingredient and Polyvinylpyrrolidon as Excipient
    Publication number: 20150290180
    Abstract: Dosage forms for oral administration of a PDE 4 inhibitor whose solubility is slight are described. They contain PVP as binder.
    Type: Application
    Filed: June 9, 2015
    Publication date: October 15, 2015
    Inventors: Rango Dietrich, Klaus Eistetter, Hartmut Ney
  • Oral Dosage Form Containing A PDE 4 Inhibitor as an Active Ingredient and Polyvinylpyrrolidon as Excipient
    Publication number: 20150290178
    Abstract: Dosage forms for oral administration of a PDE 4 inhibitor whose solubility is slight are described. They contain PVP as binder.
    Type: Application
    Filed: June 5, 2015
    Publication date: October 15, 2015
    Inventors: Rango Dietrich, Klaus Eistetter, Hartmut Ney
  • Oral Dosage Form Containing A PDE 4 Inhibitor as an Active Ingredient and Polyvinylpyrrolidon as Excipient
    Publication number: 20150290179
    Abstract: Dosage forms for oral administration of a PDE 4 inhibitor whose solubility is slight are described. They contain PVP as binder.
    Type: Application
    Filed: June 9, 2015
    Publication date: October 15, 2015
    Inventors: Rango Dietrich, Klaus Eistetter, Hartmut Ney
  • Oral Dosage Form Containing A Pde 4 Inhibitor As An Active Ingredient And Polyvinylpyrrolidon As Excipient
    Publication number: 20140031396
    Abstract: Dosage forms for oral administration of a PDE 4 inhibitor whose solubility is slight are described. They contain PVP binder.
    Type: Application
    Filed: September 26, 2013
    Publication date: January 30, 2014
    Applicant: Takeda GmbH
    Inventors: Rango Dietrich, Klaus Eistetter, Hartmut Ney
  • Oral Dosage Form Containing A Pde 4 Inhibitor As An Active Ingredient And Polyvinylpyrrolidon As Excipient
    Publication number: 20140031397
    Abstract: Dosage forms for oral administration of a PDE 4 inhibitor whose solubility is slight are described. They contain PVP as binder.
    Type: Application
    Filed: September 26, 2013
    Publication date: January 30, 2014
    Applicant: Takeda GmbH
    Inventors: Rango Dietrich, Klaus Eistetter, Hartmut Ney
  • Oral Dosage Form Containing A Pde 4 Inhibitor As An Active Ingredient And Polyvinylpyrrolidon As Excipient
    Publication number: 20130345265
    Abstract: Dosage forms for oral administration of a PDE 4 inhibitor whose solubility is slight are described. They contain PVP as binder.
    Type: Application
    Filed: April 30, 2013
    Publication date: December 26, 2013
    Applicant: Takeda GmbH
    Inventors: Rango Dietrich, Klaus Eistetter, Hartmut Ney
  • Oral Dosage Form Containing A Pde 4 Inhibitor As An Active Ingredient And Polyvinylpyrrolidon As Excipient
    Publication number: 20130131123
    Abstract: An immediate release solid dosage form in tablet or pellet form for oral administration of a PDE 4 inhibitor, comprising a PDE 4 inhibitor that is N-(3,5-dichloropyrid-4-yl)-3-cyclopropylmethoxy-4-difluoromethoxybenzamide (roflumilast) or a salt thereof, and one or more suitable pharmaceutical excipients; wherein said dosage form contains 500 ?g of the roflumilast or salt thereof.
    Type: Application
    Filed: January 11, 2013
    Publication date: May 23, 2013
    Applicant: Nycomed GmbH
    Inventors: Rango DIETRICH, Hartmut NEY, Klaus EISTETTER
  • Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidone as excipient
    Patent number: 8431154
    Abstract: Dosage forms for oral administration of a PDE 4 inhibitor whose solubility is slight are described. They contain PVP as binder.
    Type: Grant
    Filed: January 18, 2011
    Date of Patent: April 30, 2013
    Assignee: Takeda GmbH
    Inventors: Rango Dietrich, Klaus Eistetter, Hartmut Ney
  • Oral Dosage Form Containing A PDE 4 Inhibitor As An Active Ingredient And Polyvinylpyrrolidone As Excipient
    Publication number: 20110251244
    Abstract: Dosage forms for oral administration of a PDE 4 inhibitor whose solubility is slight are described. They contain PVP as binder.
    Type: Application
    Filed: January 18, 2011
    Publication date: October 13, 2011
    Applicant: NYCOMED GMBH
    Inventors: Rango Dietrich, Hartmut Ney, Klaus Eistetter
  • Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient
    Patent number: 7951397
    Abstract: Dosage forms for oral administration of a PDE 4 inhibitor whose solubility is slight are described. They contain PVP as binder.
    Type: Grant
    Filed: February 19, 2003
    Date of Patent: May 31, 2011
    Assignee: Nycomed GmbH
    Inventors: Rango Dietrich, Klaus Eistetter, Hartmut Ney
  • Oral dosage form containing a pde 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient
    Publication number: 20110060016
    Abstract: Disclosed is a method of treatment of COPD by oral administration of roflumilast.
    Type: Application
    Filed: September 7, 2010
    Publication date: March 10, 2011
    Applicant: NYCOMED GMBH
    Inventors: Rango Dietrich, Hartmut Ney, Klaus Eistetter
  • Device for Dosing and Dry Nebulization
    Publication number: 20090211577
    Abstract: The invention relates to a device 1 for dosing and dry nebulization of nebulizable material 12 chosen from the group comprising anti-infective agents and immunomodulators, comprising a nebulization channel 3, which has a first attachment piece and a second attachment piece, and a source of compressed carrier gas connected to the first attachment piece via a valve 16 for the purpose of sending a carrier gas pressure pulse into the nebulization channel. The device is characterized in that between the first attachment piece and second attachment piece, and above the nebulization channel, a reservoir 10 open only towards the nebulization channel, which contains the nebulizable material 12, is connected to the nebulization channel such that it is gas-tight with respect to the environment, and that, when the valve is closed, a pressure compensation takes place in the nebulization channel and in the reservoir.
    Type: Application
    Filed: April 7, 2006
    Publication date: August 27, 2009
    Applicant: NYCOMED GMBH
    Inventors: Klaus Eistetter, Wilhelm Wurst, Gerhard Pohlmann, Horst Windt, Oliver Nolte, Wolfgang Koch
  • Use of Surfactant Preparations for the Treatment of Surgical Adhesions
    Publication number: 20090011978
    Abstract: The invention describes the use of surfactant comprising phospholipids and pulmonary surfactant proteins for the treatment of surgical adhesions.
    Type: Application
    Filed: August 27, 2004
    Publication date: January 8, 2009
    Applicant: Atlanta Pharma AG
    Inventors: Dietrich Hafner, Ralf Harand, Eva Ammon, Ernst Sturm, Klaus Eistetter, Friedemann Taut, Thomas Muller
  • Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient
    Publication number: 20060269600
    Abstract: Dosage forms for oral administration of a PDE4 inhibitor whose solubility is slight are described. They contain PVP as a binder.
    Type: Application
    Filed: August 10, 2006
    Publication date: November 30, 2006
    Inventors: Rango Dietrich, Hartmut Ney, Klaus Eistetter
  • Use of ciclesonide for the treatment of inflammatory bowel diseases
    Publication number: 20060211668
    Abstract: The invention relates to the novel use of ciclesonide in the treatment of inflammatory bowel disease.
    Type: Application
    Filed: September 15, 2004
    Publication date: September 21, 2006
    Applicant: ALTANA PHARMA AG
    Inventors: Florian Abel, Antje Brueck, Klaus Dietzel, Klaus Eistetter, Ruediger Nave, Stefan Postius, Oliver Von Richter
  • Compositions
    Patent number: 6998410
    Abstract: Novel compositions for the treatment of IRDS and ARDS are indicated which contain N-(3,5-dichloro-pyrid-4-yl)-3-cyclopropylmethoxy-4-difluoromethoxybenzamide and/or its pharmacologically tolerable salts and lung surfactant.
    Type: Grant
    Filed: March 13, 2002
    Date of Patent: February 14, 2006
    Assignee: Altana Pharma AG
    Inventors: Dietrich Hafner, Klaus Eistetter
  • Oral dosage form containing a pde 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient
    Publication number: 20050159492
    Abstract: Dosage forms for oral administration of a PDE 4 inhibitor whose solubility is slight are described. They contain PVP as binder.
    Type: Application
    Filed: February 19, 2003
    Publication date: July 21, 2005
    Applicant: Altana Pharma AG
    Inventors: Rango Dietrich, Hartmut Ney, Klaus Eistetter
  • Compositions for the treatment of ARDS or IRDS containing 3-(cycloproplymethoxy)-N-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy) benzamide and lung surfactant
    Patent number: 6436970
    Abstract: Compositions for treating IRDS and ARDS contain N-(3,5-dichloropyrid-4-yl)3-cyclopropylmethoxy-4-difluoromethoxybenzamide and/or a pharmacologically tolerable salt thereof and lung surfactant.
    Type: Grant
    Filed: August 6, 1999
    Date of Patent: August 20, 2002
    Assignee: Byk Gulden Lomberg Chemische Febrik GmbH
    Inventors: Dietrich Häfner, Klaus Eistetter